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THE cytotoxic effects of many chemotherapeutic agents used in the treatment
of cancer are more evident in dividing than resting cells. Cells dividing during
exposure to a drug tend to suffer greater immediate damage than interphase cells.
Injury during mitosis may also reflect inapparent antecedent effects of a drug.
HeLa carcinoma cells treated with dextran-saline solutions in vitro showed both
of these responses (Powell, 1961). Post-prophase dividing cells were killed dur-
ing treatment ; other cells grew normally for several days after treatment but
then developed lethal mitotic lesions. Such factors may be partly responsible
for the relative vulnerability of many tumours with high mitotic incidences to
general cytotoxic agents.
Compounds with a marked selective actioni against malignant cells have ain
inherent therapeutic advantage. Although the results of chemotherapeutic trials
on cultivated tissues cannot be extrapolated without reservations to in vivo
conditions, in vitro methods can be used to identify drugs with a selective
effect on tumour cells. The results of trials with 2-(2 6-xylyloxy)ethylguani-
(line are described. This compound has been found to destroy preferentially
dividing sarcoma cells grown in vitro. At the effective drug concentrations inter-
phase sarcoma cells were much less affected and normal fibrocytes grew rapidly.
MATERIALS AND METHODS
Comparative studies were made on explants of a typical undifferentiated
mouse sarcoma and mouse enbryo muscle grown apart on the same coverslips.
This tumour has been maintained for more than two years by serial transplanta-
tion in RIII strain mice. It had developed by sarcomatous transformation
during the early stages of the propagation of a spontaneous mammary carcinoma.
Explants for cultivation, 1-2 mm.3 in size, were prepared in serum-balanced
saline solution from the cortex of actively growing tumours and thigh muscle from
14-16-day-old RIII strain mouse embryos. A single tumour provided enough
explants for a set of cultures but it was necessary to pool muscle tissue from sib
embryos.
Explants were mounted on roller-tube coverslips in thin coagula consisting of
2 parts of fowl plasma and 1 part each of calf serum and chick embryo extract.
The last was prepared as described previously (Powell, 1960). Each coverslip
carried a muscle and a tumour explant set about 1 cm. apart. The occasional
contamination of one explant with cells from the other was not disadvantageous.A. K. POWELL
The sarcoma cells were easily distinguished from the normal fibrocytes. Each
roller-tube carried 6 coverslips which were provided with 4 ml. of culture medium.
The cultures were grown for 5-6 days before treatment to develop optimum out-
growths for study.
Normal control culture medium and experimental medium containing 2-
(2: 6-xylyloxy)ethylguanidine over a range of fractional molar concentrations
were prepared from the same batches of stock components. The normal medium
consisted of 30 per cent native calf serum and 70 per cent nutritive supplement
No. 199 devised by Morgan, Morton and Parker (1950). The latter was obtained
as the 10-fold concentrate from Glaxo Laboratories. It differed from the original
formulation in containing penicillin and streptomycin, and in the substitution of
Hank's for Earle's balanced saline solution. The control medium was adequate
for progressive growth of control cultures and did not impair the coagula. The
test media were the same asthe control medium exceptfortheinclusion ofthe drug.
A solution of 0*6460 per cent (w/v) of 2-(2: 6-xylyloxy)ethylguanidine sul-
phate monohydrate in de-ionized water was sterilized by Seitz filtration. The
filter pads were percolated with excess of the drug solution beforehand. The
aqueous drug solution was then diluted with an equal volume of double strength
T.C.M. 199 to give M/50 drug concentration in standard T.C.M. 199 Hank's
saline. Culture medium containing the drug at m/100 concentration was prepared
directly from the M/50 drug solution. Test media containing the lower drug
concentrations were prepared by serial dilution of the M/100 medium with normal
control medium. These were M/250, M/1000, M/5000, M/25,000 and M/100,000,
respectively.
The experiments were done in triplicate and the cultures revolved at 370 C.
Cultures were fed with normal medium 24 hours before treatment. Control and
treated cultures were fed daily with 4 ml of medium, prewarmed to 37° C., for
the duration of the experiments. Media were stored at -40° C.
Cultures were fixed daily in " Sus% " and stained with Ehrlich's haematoxylin
and eosin. The No. 2 culture coverslips were mounted under matching No. 0
coverslips.
EXPERIMENTAL RESULTS
Exposure to M/100, M/250 and M/1000 drug concentrations in the culture
medium rapidly killed both normal and malignant cells. None survived the
first day of treatment. The lowest of these concentrations produced the most
obvious cytological damage. Cultures fixed 24 hours after the initial treatment
with M/1000 drug medium were grossly degenerated. Both sarcoma cells and
normal fibrocytes had the necrotic appearance typical of well advanced autolysis.
This indicated that the cells had died very soon after exposure to the drug.
EXPLANATION OF PLATE
FIG. 1. Dead myoblast in outgrowth from muscle explant treated with M/100 2-(2: 6-
xylyloxy)ethylguanidine for 24 hours.
FIG. 2.-Viable interphase and injured dividing cells in outgrowth from sarcoma explant treated
with M/5000 2-(2: 6-xylyloxy)ethylguanidine for 24 hours.
FIG. 3.-A multipolar dividing cell and viable interphase cells in outgrowth from sarcoma
explant treated with M/5000 2-(2: 6-xylyloxy)ethylguanidine for 72 hours.
FIG. 4.-Viable anaphase cell and interphase fibrocytes in outgrowth from muscle explant
treated with M/5000 2-(2: 6-xylyloxy)ethylguanidine for 96 hours.
294BRITISH JOURNAL OF CANCER.
I 2
Powell.
VOl. XVII NO. 2.EFFECTS OF 2-(2: 6-XYLYLOXY)-ETHYLGUANIDINE
Pyknotic malformed nuclei and nuclear fragments, and disintegrating, strongly
acidophilic cytoplasm were typical.
M/100 and M/250 concentrations of the drug were as lethal but resulted in
much less autolysis and cell destruction. The treated cells preserved much of
their original structure. It appeared that these two higher drug concentrations
inactivated cytolytic enzymes before marked autolysis took place. Unlike cells
exposed to M/250 drug medium, those treated with M/100 drug medium did not
commonly have nuclei diffusely stained by haematoxylin (Fig. 1). This could
have been caused by a more rapid removal, due to earlier cell death, of basophilic
material from nuclei of cells given the higher drug concentration. Apart from
this difference both sets of cultures looked alike. Cytological structure was well
preserved for some days. Other than decreased basophilia the main degenerative
change was in the fine nuclear structure.
Culture medium containing M/5000 concentration of the drug was not appreci-
ably toxic to cultures of normal fibrocytes during the first day of treatment.
The outgrowth fibrocytes were healthy and growing. The presence of cyto-
plasmic droplets, derived from processes of cells at the extreme edge of the out-
growths, indicated a slight toxicity. The peripheral fibrocytes also tended to be
flattened and enlarged but were viable. Dead and degenerated cells were no
commoner than in untreated controls.
Interphase sarcoma cells in the collateral cultures were usually healthy (Fig. 2)
except that, as with the normal fibrocytes, cytoplasmic processes of peripheral
cells were often hypertrophied and sometimes broken into small droplets.
Untreated sarcoma cultures always included a small minority of degenerating
dividing cells but grew progressively. In the 24-hour-old cultures treated with
M/5000 drug medium almost all dividing sarcoma cells were destroyed (Fig. 2), but
the comparable dividing fibrocytes were normal. Pathological metaphases were
abundant in the sarcoma outgrowths but anaphases and telophases were very
rare. These injured cells contained irregular pyknotic masses derived from fused
chromosomes. Some cells had rounded and smoother pyknotic nuclear masses.
A low incidence of apparently normal prophases was found. Occasional viable
metaphases were seen in the immediate vicinity ofthe explants where the sarcoma
cells were closely packed. In view of the toxicity of the drug to metaphase cells
in the outgrowth it was probable that the viable metaphase cells had recently
migrated the short distances from the explant itself.
Exposure to M/5000 drug concentration for 48 hours did not inhibit the growth
of the normal fibrocyte cultures. The outgrowth cells were healthy and actively
dividing. Resting sarcoma cells also showedno furtherdeterioration. Thetumour
cultures were actively dividing. Tripolar divisions were unusually abundant,
most metaphases were abortive, anaphase bridges and dead telophases common.
Viable mitoses were observed near the explants. It appeared that the exposed
outgrowth tumour cells were injured during mitosis but that tumour cells emerg-
ing from the explants ready to divide often successfully completed mitosis.
After treatment for 72 hours in M/5000 drug medium, dividing cells were com-
mon in the sarcoma cultures but all mitotic phases, other than prophases, were
usually pathological. Most of the telophase cells were killed. Occasional
abnormal metaphases, like those induced by colchicine, were found but most were
of the pyknotic type. Aberrant multipolar divisions were also present (Fig. 3).
All dividing sarcoma cells were recent migrants from the explants. Inter-
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phase tumour cells were usually viable (Fig. 3); degenerated ones were not
numerous. The sarcoma cultures showed no net growth and the original out-
growth area was not exceeded. Comparable fibrocyte cultures grew vigorously
and mitoses were normal. After further treatment for 4 and 5 days the total
population of tumour cells had decreased. This was due to deaths of dividing
cells. Interphase tumour cells were still viable at this time but less healthy.
Unlike the involuting sarcoma cultures the collateral muscle cultures grew (Fig. 4)
throughout the exposure to this drug concentration.
The fibrocyte cultures were also unaffected by media containing the drug at
concentrations of M/25,000 and M/100,000. Interphase tumour cells were also
undamaged. Dividing tumour cells were injured as described for M/5000 drug
medium although the proportion of successful mitoses increased with the further
dilutions ofthe drug. After treatment for 5 days, the M/25,000 drug medium had
permitted only slight overall increase in area of the outgrowths. Sarcoma cul-
tures treated with the M/100,000 drug medium did, however, grow progressively
after the first day. Parallel with this increased amount ofgrowth, the proportion
of cells killed during division decreased.
In cultures exposed to each of the two lowest drug concentrations more
dividing outgrowth cells were damaged on the second than on the first day of
treatment. This suggested cumulative damage. In M/5000 drug concentration
those metaphase cells initially dividing at the applhcation of the drug were killed
during the first day. Coeval anaphases and telophases may have completed
mitosis and cells entering division during treatment were usually killed at meta-
phase. After the second day of treatment in this drug concentration the degree
of damage to dividing outgrowth cells remained constant. The increased inci-
dence of divisions on the second day, even though most were abnormal, seemed
anomalous. There was, however, a parallel between this situation and that
found after excision or death in situ of a sector of a stabilised outgrowth. In
the latter cells grew out and divided to fill the vacant space (Willmer, 1954).
The immediate effects of the drug on pre-existing divisions were less marked
on individual chromosomes at the lower concentrations. The chromosomes
were sharper, less degenerated and less sticky. Abnormal metaphases finally
ballooned out to spherical acidophilic cytoplasmic residues studded with baso-
philic droplets of chromatin material. Sarcoma cells within the explants were
mutually protected from the effects of the drug and were able to grow into the
outgrowth areas. Thereafter their migration was impeded and divisions injured.
The essential patterns of the toxic effects of the drug at the different concentra-
tions were evident after treatment for 5 days.
DISCUSSION
Continuous exposure to 2-(2: 6-xylyloxy)ethylguanidine at concentrations of
M/100, M/250 and M/1000 in culture medium rapidly killed all treated fibrocytes
and sarcoma cells. At M/5000 concentration the drug was selectively toxic to
dividing sarcoma cells. The toxic effects were found in all division phases later
than prophase but were especially evident at metaphase. This difference was
probably associated with the dissolution of the nuclear membrane after prophase.
The preponderance of lethal divisions in sarcoma cultures treated with M/5000
drug solution caused them to involute. At M/25,000 drug concentration, in
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which the tumour cultures were almost static, the proportions of unsuccessful
and completed mitoses were about equal.
The frequency of abortive cell divisions in untreated fibrocyte cultures was
negligible. In contrast, untreated tumour cultures had invariably a significant
incidence of pathological mitoses. This predisposition of sarcoma cells to die in
division may have underlain the selective effects of the drug at concentrations
tolerated by normal fibrocytes. The mode of action of 2-(2: 6-xylyloxy)ethyl-
guanidine has not been studied but cytological evidence suggested that it affected
both the mitotic spindle and formed chromosomes. It may be relevant that
guanidine itself is an effective protein dispersant. The drug was most active
against sarcoma cells exposed in the outgrowths. The explants themselves
provided reserves of relatively unaffected cells which were stimulated to migrate
to the outgrowth areas and divide by the cultural methods used. This sequence
reduced the net cell populations of the tumour cultures at the operative drug
concentration.
SUMMARY
Normal mouse fibrocytes and sarcoma cells cultivated in vitro were treated
continuously with 2-(2: 6-xylyloxy)ethylguanidine.
All treated cells were rapidly killed by this cytotoxic agent at concentrations
of M/100, M/250 and M/1000 in the culture medium.
At the M/5000 concentration the drug was selectively toxic to dividing
sarcoma cells but only slightly affected interphase sarcoma cells. Destruction of
dividing cells caused the tumour cultures to involute. Divisions were normal in
the fibrocyte cultures, which grew progressively.
The ratios of unsuccessful and complete divisions of the sarcoma cells were
about equal and the cultures remained almost static in medium containing the
M/25,000 drug concentration.
The sarcoma cultures grew progressively in medium containing M/100,000
drug concentration which was only slightly toxic.
I am indebted to Mr. G. A. Butcher, Mr. F. Butcher and Mr. M. Sewell-Rutter
for their valuable technical assistance. Messrs. Smith, Kline and French
generously provided the sample of 2-(2: 6-xylyloxy)ethylguanidine sulphate
monohydrate.
The expenses of this work were defrayed from a block grant by the British
Empire Cancer Campaign.
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